Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Нарушения сна у зависимых от различных психоактивных веществ

СПИСОК ЛИТЕРАТУРЫ

  1. Ветрова М. В., Кучменко Д. Н., Генина И. Н., Гончаров О. В., Рыбакова К. В., Семенова Н. В., Зубова Е. Ю., Киселев А. С., Незнанов Н. Г., Крупицкий Е. М. Распространенность нарушений сна среди пациентов с зависимостью от различных психоактивных веществ. Бюллетень сибирской медицины. 2019; 18(4): 26–35.
  2. Ветрова М. В., Рыбакова К. В., Гончаров О. В., Кучменко Д. Н., Генина И. Н., Семенова Н. В., Макаров И. В., Зубова Е. Ю., Незнанов Н. Г., Крупицкий Е. М. Особенности нарушений сна при употреблении различных психоактивных веществ. Журнал неврологии и психиатрии им. C. C. Корсакова. 2020; 120(5): 153–159.
  3. Михайлов В. А., Полуэктов М. Г., Полторак С. В. Левин Я. И., Поляков А. Ю., Стрыгин К. Н., Бабак С. Л. Клинические и нейрофизиологические характеристики нарушений сна у больных с тревожными расстройствами и способы их коррекции. Обозрение психиатрии и медицинской психологии им. В. М. Бехтерева. 2013; 3: 81–88.
  4. Aldrich M. S., Shipley J. E., Tandon R., Kroll P. D., Brower K. J. Sleep‐Disordered Breathing in Alcoholics: Association with Age. Alcohol. Clin. Exp. Res. 1993; 17(6): 1179–1183. doi:10.1111/j.1530-0277.1993.tb05224.x.
  5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Arlington, VA: American Psychiatric Publishing, 2013; 992. doi:10.1176/ appi.books.9780890425596.
  6. Angarita G. A., Emadi N., Hodges S., Morgan P. T. Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review. Addict. Sci. Clin. Pract. 2016; 11: 9. doi: 10.1186/s13722-016-0056-7.
  7. Angarita G. A., Canavan S. V., Forselius E., Bessette A., Pittman B., Morgan P. T. Abstinence-related changes in sleep during treatment for cocaine dependence. Drug Alcohol. Depend. 2014; 134(1): 343–347. doi:10.1016/j.drugalcdep.2013.11.007.
  8. Angarita G. A., Canavan S. V., Hodges S. E., Morgan P. T. Sleep and Cocaine. Т 2. Elsevier Inc.; 2016. doi:10.1016/B978-0-12-800212-4.00021-2.
  9. Anothaisintawee T., Reutrakul S., Van Cauter E., Thakkinstian A. Sleep disturbances compared to traditional risk factors for diabetes development: systematic review and meta-analysis. Sleep Med. Rev., 2015; 30: 11–24.
  10. American Academy of Sleep Medicine. International Classification of Sleep Disorders. 3rd ed. Darien, IL : American Academy of Sleep Medicine. 2014.
  11. Asaad T. A, Ghanem M. H., Abdel Samee A. M., El-habiby M. M. Sleep profile in patients with chronic opioid abuse: A polysomnographic evaluation in an Egyptian sample. Addict. Disord their Treat. 2011; 10(1): 21–28. doi:10.1097/ADT.0b013e3181fb2847.
  12. Aurora R. N., Kristo D. A., Bista S. R., Rowley J. A., Zak R. S., Casey K. R., Lamm C. I., Tracy S. L., Rosenberg R. S., American Academy of Sleep Medicine. The treatment of restless legs syndrome and periodic limb movement disorder in adults — an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep. 2012; 35(8): 1039–1062. doi:10.5665/sleep.1988.
  13. Baglioni C., Battagliese G., Feige B. et al. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J. Affect. Disord., 2011, 135: 10–19.
  14. Bayon V., Leger D., Gomez-Merino N., Vecchierini M. F., Chennaoui M. Sleep debt and obesity. Ann. Med., 2014; 46: 264–272.
  15. Bowles N. P., Herzig M. X., Shea St. A. Recent legalization of cannabis use: effects on sleep, health, and workplace safety. Nat Sci Sleep. 2017; 9: 249–251. doi: 10.2147/NSS.S152231.
  16. Brower K. J. Alcohol’s Effects on Sleep in Alcoholics. Alcohol Res Heal. 2001; 25(2): 110–125.
  17. Brower K. J. Insomnia, alcoholism and relapse. 2003; 7(6): 523–539.
  18. Brower K. J., Perron B. E. Prevalence and Correlates of Withdrawal-Related Insomnia among Adults with Alcohol Dependence: Results from a National Survey. Am. J. Addict. 2010; 19(3): 238–244. doi:10.1111/j.1521-0391.2010.00035.x.
  19. Brower K. J., Aldrich M. S., Robinson E. A., Zucker R. A., Greden J. F. Insomnia, self-medication, and relapse to alcoholism. Am. J. Psychiatry. 2001; 158(3): 399-404. doi: 10.1176/appi. ajp.158.3.399.
  20. Brower K. J., Perron B. E. Sleep disturbanse as a universal risk factor for relapese in addictions to psychoactive substances. Med. Hypotheses. 2010; 74(5): 928-933. doi:10.1016/j. mehg.2009.10.020.
  21. Budney A. J., Moore B. A., Vandrey R. G., Huges J. R. The time course and significance of cannabis withdrawal. J. Abnorm. Psychol. 2003; 112(3): 393–402.
  22. Buxton O. M., Marcelli E. Short and long sleep are positively associated with obesity, diabetes, hypertension, and cardiovascular disease among adults in the United States. Soc. Sci. Med., 2010; 71: 1027–1036.
  23. Cappuccio F. P., D’Elia L., Strazzullo P., Miller M. A. Quantity and quality of sleep and inci- dence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care, 2010; 33: 414–420.
  24. Conroy D. A., Arnedt J. T. Sleep and Substance Use Disorders: An Update. Curr. Psychiatry Rep. 2014; 16(10). doi:10.1007/s11920-014-0487-3.
  25. Dijkstra B. A. G., De Jong C. A. J., Krabbe P. F. M., Van Der Staak C. P. F. Prediction of abstinence in opioid-dependent patients. J. Addict. Med. 2008; 2(4): 194–201. doi:10.1097/ADM. 0b013e31818a6596.
  26. Dimsdale J. E., Norman D., DeJardin D., Wallace M. S. The effect of opioids on sleep architecture. J. Clin. Sleep. Med. 2007; 3(1): 33–36. doi:10.1016/0024-3205(82)90138-2.
  27. Drummond S. P. A., Gillin J. C., Smith T. L., Demodena A. The Sleep of Abstinent Pure Primary Alcoholic Patients: Natural Course and Relationship to Relapse. 1998; 22(8):1796–1802.
  28. Faraut B., Touchette E., Gamble H. et al. Short sleep duration and increased risk of hypertension: a primary care medicine investigation. J. Hypertens. 2012; 30: 1354–1363.
  29. Gillin J. C., Smith T. L., Irwin M., Kripke D. F., Brown S., Schuckit M. Short REM latency in primary alcoholic patients with secondary depression. Am. J. Psychiatry. 1990; 147(1): 106.
  30. Gordon H. W. Differential Effects of Addictive Drugs on Sleep and Sleep Stages. J. Addict. Res. (OPAST Group). 2019; 3(2): 10.33140/JAR.03.02.01. doi: 10.33140/JAR.03.02.01.
  31. Irwin M. R., Bjurstrom M. F., Olmstead R. Polysomnographic measures of sleep in cocaine dependence and alcohol dependence: Implications for age-related loss of slow wave, stage 3 sleep. Addiction. 2016; 111(6): 1084–1092. doi:10.1111/add.13300.
  32. Jacox A., Carr D. B., Payne R. New clinical-practice guidelines for the management of pain in patients with cancer. N. Engl. J. Med. 1994; 330(9): 651–655. doi:10.1056/ NEJM199307083290201.
  33. Laugsand L. E., Strand L. B., Platou C., Vatten L. J., Janszky I. Insomnia and the risk of incident heart failure: a population study. Eur. Heart J. 2014; 35: 1382–1393.
  34. Laugsand L. E., Vatten L. J., Platou C., Janszky I. Insomnia and the risk of acute myocardial infarction: a population study. Circulation. 2011; 124: 2073–2081.
  35. Li M., Zhang X. W., Hou W. S., Tang Z. Y. Insomnia and risk of cardiovascular disease: a meta- analysis of cohort studies. Int. J. Cardiol. 2014; 176: 1044–1047.
  36. Liu T. Z., Xu C., Rota M. et al. Sleep duration and risk of all-cause mortality: a flexible, non-linear, meta-regression of 40 prospective cohort studies. Sleep Med. Rev., 2017; 32: 28–36.
  37. Mayer G., Jennum P., Riemann D., Dauvilliers Y. Insomnia in central neurologic diseases — occurrence and management. Sleep Med. Rev. 2011; 15: 369–378.
  38. Meng L., Zheng Y., Hui R. The relationship of sleep duration and insomnia to risk of hypertension incidence: a meta-analysis of prospective cohort studies. Hypertens. Res. 2013; 36: 985–995.
  39. Murillo-Rodriguez E., Millán-Aldaco D., Palomero-Rivero M., Mechoulam R., Drucker-Colín R. Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats. FEBS Lett. 2006; 580(18): 4337–4345.
  40. Nicholson A. N., Turner C., Stone B. M., Robson P. J. Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J. Clin. Psychopharmacol. 2004; 24(3): 305–313.
  41. Nordmann S., Lions C., Vilotitch A., Michel L., Mora M., Spire B., Maradan G., Morel A., Roux P., Carrieri M. P., ANRS Methaville study group. A prospective, longitudinal study of sleep disturbance and comorbidity in opiate dependence (the ANRS Methaville study). Psycho-pharmacology (Berl). 2016; 233(7): 1203–1213. doi:10.1007/s00213-016-4202-4.
  42. Osorio R. S., Pirraglia E., Aguera-Ortiz L. F. et al. Greater risk of Alzheimer’s disease in older adults with insomnia. J. Am. Geriatr. Soc. 2011; 59: 559–562.
  43. Palagini L., Bruno R. M., Gemignani A., Baglioni C., Ghiadoni L., Riemann D. Sleep loss and hypertension: a systematic review. Curr. Pharm. Des. 2013; 19: 2409–2419.
  44. Patel S. R., Hu F. B. Short sleep duration and weight gain: a systematic review. Obesity. 2008; 16: 643–653.
  45. Paunio T., Korhonen T., Hublin C. et al. Poor sleep predicts symptoms of depression and disability retirement due to depression. J. Affect. Disord., 2015; 172: 381–389.
  46. Peles E., Schreiber S., Bar Hamburger R., Adelson M. No Change of Sleep after 6 and 12 months of methadone maintenance treatment. J. Addict. Med. 2011; 5(2):141–147. doi:10.1097/ ADM.0b013e3181e8b6c4.
  47. Riemann D., Voderholzer U. Primary insomnia: a risk factor to develop depression? J. Affect. Disord. 2003; 76: 255–259.
  48. Roehers T. A., Roth T. Sleep Disturbance in Substance Use Disorders. Psychiatr. Clin. North Am. 2015. 38(4): 793–803, doi: 10.1016/s.psc.2015.07.008.
  49. Sexton C. E., Storsve A. B., Walhovd K. B., Johansen-Berg H., Fjell A. M. Poor sleep quality is associated with increased cortical atrophy in community-dwelling adults. Neurology. 2014; 83: 967–973.
  50. Sofi F., Cesari F., Casini A., Macchi C., Abbate R., Gensini G. F. Insomnia and risk of cardiovascular disease: a meta-analysis. Eur. J. Prev. Cardiol. 2014; 21: 57–64.
  51. Stein M., Friedmann P. Disturbed sleep and its relationship to alcohol use. Subst. Abus. Off Publ. Assoc. Med. Educ. Res. Subst. Abus. 2005; 26(1): 1–13. doi:10.1300/J465v26n01.
  52. Vitiello M. V. Sleep, alcohol and alcohol abuse. Addict Biol. 1997; 2(2): 151–158. doi: 10.1080/13556219772697l.
  53. Wang D., Teichtahl H., Goodman C., Drummer O., Grunstein R. R., Kronborg I. Subjective daytime sleepiness and daytime function in patients on stable methadone maintenance treatment: possible mechanisms. J. Clin. Sleep Med. 2008; 4(6): 557–562. URL: http://www.ncbi.nlm.nih.gov/pubmed/19110885.
  54. Xiao L., Tang Y. lang, Smith A. K., Xiang Y. T., Sheng L. X., Chi Y., Du W. J., Guo S., Jiang Z. N., Zhang G. F., Luo X. N. Nocturnal sleep architecture disturbances in early methadone treatment patients. Psychiatry Res. 2010; 179(1): 91–95. doi:10.1016/j.psychres.2009.02.003.
  55. Yaffe K., Falvey C. M., Hoang T. Connections between sleep and cognition in older adults. Lancet Neurol. 2014; 13: 1017–1028.
  56. Young-McCaughan S., Miaskowski C. Definition of and mechanism for opioid-induced sedation. Pain Manag. Nurs. 2001; 2(3): 84–97. doi:10.1053/jpmn.2001.25012.

Для продолжения работы требуется Регистрация
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
СПИСОК ЛИТЕРАТУРЫ
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Оглавление

Данный блок поддерживает скрол*